In breast cancer and embryonic cancer cells, FABP3 acts as a tumor suppressor [41]: FABP3 inactivation inhibits apoptosis and promotes proliferation; while FABP3 acts as an oncogene in gastric carcinoma, brain tumor and small cell lung cancer [42]. This evidence concerns the gene FABP3 and small cell lung carcinoma.